InvestorsHub Logo
Followers 53
Posts 1776
Boards Moderated 0
Alias Born 03/22/2015

Re: no2koolaid post# 365525

Friday, 02/11/2022 12:59:20 PM

Friday, February 11, 2022 12:59:20 PM

Post# of 401679
Wrong.



A worthy question. But not worded in a way that a CEO of a business, even a little business like Elite, could answer.

Now why is that?

Imagine for a moment Elite is working on an ANDA different in the ways that are inferred. Why would a CEO reveal answers that are likely the basis for product development?






This assessment is completely wrong. The question is not designed for Nasrat to reveal his genius to us. The question is designed to determine how full of shit he is. If he continues to talk like naltrexone can be used as an antagonist ADF for CNS stimulants, then he is talking about magic beans, and everyone deserves to be aware he is not in touch with the realities of molecular biology. Hanlon's razor will be fully resolved, and incompetence is the winner. Make your decisions thusly.

Sell the news, because this dog will not hunt. It isn't going anywhere good in the long run, just like the last eight years. I'm hoping the question alone helps him to focus and realize the practicalities of receptor affinity are not dependent on his opinions. Just like the Apple Sauce Escapades and Zombie SequestOx, Nasrat needs a little help occasionally staying in the proper lane, and for the time being at least, I'm here to nudge him back on the right track when necessary. You're welcome.



Once again, medical knowledge is one thing and investing in business another. But assuredly, both are very far from the knowledge needed to actually run a business effectively.




Common sense works pretty good. I encourage all investors to try it out.





#FreeSequestOx


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News